Multiple Sclerosis (MS) is a serious neurological disease that is difficult to diagnose and also challenging to manage.  People with the Multiple Sclerosis (MS) generally suffer from vitamin D deficiency. A low level of vitamin D is related to development of MS disease.  MS patients with low level of vitamin D are prone to more disability and a higher degree of MS activity.  Vitamin D is essential for bone health and regulation of immune system.

Aim

In this pilot study, the effect of low dose cholecalciferol (LDC) and high dose ergocalciferol (HDE) on the Vitamin D levels in people with MS has been studied. Vitamin D levels of 40 MS patients were evaluated, who took either LDC or HDE.

Results

The large number of MS patients were vitamin D deficient and the HDE increased noticeably the level of vitamin D. HDE was more efficient than LDC in increasing vitamin D level.

Conclusion

Although the researchers are still investigating the required daily amount of vitamin D for people with MS, but so far it is recommended a daily supplement of 40-60 nanograms per milliliter (ng/mL) vitamin D.

Reference